Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| SANDOZ AFATINIB | Sandoz Canada, Inc. | Marketed | Oct 28, 2024 | Marketed |
| SPEVIGO | boehringer ingelheim (canada) ltd ltee | Marketed | Oct 28, 2024 | Marketed |
| MINT-VARENICLINE | mint pharmaceuticals inc | Marketed | Oct 28, 2024 | Marketed |
| TIBSOVO | servier canada inc | Marketed | Oct 28, 2024 | Marketed |
| MINT-VARENICLINE | mint pharmaceuticals inc | Marketed | Oct 28, 2024 | Marketed |
| SANDOZ AFATINIB | Sandoz Canada, Inc. | Marketed | Oct 28, 2024 | Marketed |
| NRA-PRUCALOPRIDE | nora pharma inc | Marketed | Oct 28, 2024 | Marketed |
| AURO-BILASTINE | auro pharma inc | Marketed | Oct 25, 2024 | Marketed |
| MYALEPTA | CHIESI FARMACEUTICI S.P.A. | Marketed | Oct 25, 2024 | Marketed |
| MYALEPTA | CHIESI FARMACEUTICI S.P.A. | Marketed | Oct 25, 2024 | Marketed |
| M-BILASTINE | mantra pharma inc | Marketed | Oct 24, 2024 | Marketed |
| M-MIDODRINE | mantra pharma inc | Marketed | Oct 23, 2024 | Marketed |
| MAR-BILASTINE | marcan pharmaceuticals inc | Marketed | Oct 22, 2024 | Marketed |
| GLN-BILASTINE | glenmark pharmaceuticals canada inc. | Marketed | Oct 22, 2024 | Marketed |
| ZORYVE | arcutis canada, inc. | Marketed | Oct 22, 2024 | Marketed |
| SANDOZ BILASTINE | Sandoz Canada, Inc. | Marketed | Oct 22, 2024 | Marketed |
| JAMP BILASTINE | Jamp Pharma Corporation | Marketed | Oct 22, 2024 | Marketed |
| VORANIGO | servier canada inc | Marketed | Oct 21, 2024 | Marketed |
| VORANIGO | servier canada inc | Marketed | Oct 21, 2024 | Marketed |
| MAR-METFORMIN XR | marcan pharmaceuticals inc | Marketed | Oct 21, 2024 | Marketed |
